Clinical trial
Stimulant Drug Treatment of AD/HD, Inattentive Type
NCT00824317 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stimulant Drug Treatment of AD/HD, Inattentive Type
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2001
- Completion date
- February 28, 2005
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhd